Mobile Apps

Our apps are designed to facilitate the adoption of guidelines into daily clinical practice. They put the guideline information, recommendations, and algorithms directly in the hands of practitioners in an easy to use interactive format.  

ICCS

iCCS is the all-in-one guideline app for CCS’ most popular guidelines and contains guideline summaries, introductory videos, clinical calculators, useful drug tables, clinical trial summaries, and a comprehensive library of guidelines and pocket guides.


iCCS replaces our previous individual topic guideline apps and now includes the following CCS Guidelines:

  • Atrial Fibrillation
  • Heart Failure
  • Cardiac Resynchronization Therapy
  • Dyslipidemia
  • Antiplatelet Therapy
  • Fitness to Drive/Fly
 
  Get it on iTunes Badge US 1114   en generic rgb wo 45
          
   

 

Related Guideline Apps:

app circl lipids CardioRisk Calculator™ simplifies cardiovascular risk stratification with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for diagnosis of familial hypercholesterolemia.  The CardioRisk Calculator™ includes, quick calculations on % LDL-C reductions; concise drug dosage information; clear snapshot of a patient's CV risk; options to bring lipid levels to target.

CardioRisk Calculator™ is made possible through an educational grant from Sanofi Canada through FH Canada.

   
app MED HF AHS Med-hf supports healthcare professionals in the initiation, titration, assessment and monitoring of the 4 drug classes commonly used to treat heart failure: ACEIs/ARBs, Beta-Blockers, Diuretics, Aldosterone Antagonists. Developed by Alberta Health Services in collaboration with the CCS, it guides users through evidence-based algorithms and recommends appropriate actions and considerations based on 2011 CCS Heart Failure Guidelines.
   
App icon pedhf This Paediatric Cardiac Risk Assessment app was developed by CCS to provide a concise summary of the 2009 CCS Position Statement on "Cardiac risk assessment before the use of stimulant medications in children and youth".